103 related articles for article (PubMed ID: 36170749)
21. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
22. Effects of behavioural interventions on postpartum retention and adherence among women with HIV on lifelong ART: the results of a cluster randomized trial in Kenya (the MOTIVATE trial).
Abuogi LL; Onono M; Odeny TA; Owuor K; Helova A; Hampanda K; Odwar T; Onyango D; McClure LA; Bukusi EA; Turan JM
J Int AIDS Soc; 2022 Jan; 25(1):e25852. PubMed ID: 35041776
[TBL] [Abstract][Full Text] [Related]
23. Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women.
Murnane PM; Bacchetti P; Currier JS; Brummel S; Okochi H; Phung N; Louie A; Kuncze K; Hoffman RM; Nematadzira T; Soko DK; Owor M; Saidi F; Flynn PM; Fowler MG; Gandhi M
AIDS; 2019 Aug; 33(10):1657-1662. PubMed ID: 31021852
[TBL] [Abstract][Full Text] [Related]
24. SMS messaging to improve retention and viral suppression in prevention of mother-to-child HIV transmission (PMTCT) programs in Kenya: A 3-arm randomized clinical trial.
Kinuthia J; Ronen K; Unger JA; Jiang W; Matemo D; Perrier T; Osborn L; Chohan BH; Drake AL; Richardson BA; John-Stewart G
PLoS Med; 2021 May; 18(5):e1003650. PubMed ID: 34029338
[TBL] [Abstract][Full Text] [Related]
25. Determinants of suboptimal adherence and elevated HIV viral load in pregnant women already on antiretroviral therapy when entering antenatal care in Cape Town, South Africa.
Brittain K; Remien RH; Mellins CA; Phillips TK; Zerbe A; Abrams EJ; Myer L
AIDS Care; 2018 Dec; 30(12):1517-1523. PubMed ID: 30047287
[TBL] [Abstract][Full Text] [Related]
26. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
[TBL] [Abstract][Full Text] [Related]
27. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.
Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T
PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304
[TBL] [Abstract][Full Text] [Related]
29. High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis.
Mphatswe W; Blanckenberg N; Tudor-Williams G; Prendergast A; Thobakgale C; Mkhwanazi N; McCarthy N; Walker BD; Kiepiela P; Goulder P
AIDS; 2007 Jun; 21(10):1253-61. PubMed ID: 17545701
[TBL] [Abstract][Full Text] [Related]
30. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya.
Okonji JA; Zeh C; Weidle PJ; Williamson J; Akoth B; Masaba RO; Fowler MG; Thomas TK
J Acquir Immune Defic Syndr; 2012 Oct; 61(2):249-57. PubMed ID: 22692094
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.
Gray GE; Urban M; Chersich MF; Bolton C; van Niekerk R; Violari A; Stevens W; McIntyre JA;
AIDS; 2005 Aug; 19(12):1289-97. PubMed ID: 16052084
[TBL] [Abstract][Full Text] [Related]
32. KIR-HLA and maternal-infant HIV-1 transmission in sub-Saharan Africa.
Paximadis M; Minevich G; Winchester R; Schramm DB; Gray GE; Sherman GG; Coovadia AH; Kuhn L; Tiemessen CT
PLoS One; 2011 Feb; 6(2):e16541. PubMed ID: 21346814
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life.
Desmond AC; Moodley D; Conolly CA; Castel SA; Coovadia HM
BMC Pediatr; 2015 Mar; 15():23. PubMed ID: 25885678
[TBL] [Abstract][Full Text] [Related]
34. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.
Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Maréchal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tylleskär T; Van de Perre P;
Lancet; 2016 Feb; 387(10018):566-573. PubMed ID: 26603917
[TBL] [Abstract][Full Text] [Related]
35. Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence.
Fernández-Luis S; Lain MG; Serna-Pascual M; Domínguez-Rodríguez S; Kuhn L; Liberty A; Barnabas S; Lopez-Varela E; Otwombe K; Danaviah S; Nastouli E; Palma P; Cotugno N; Spyer M; Giannuzzi V; Giaquinto C; Violari A; Cotton MF; Nhampossa T; Klein N; Ramsagar N; van Rensburg AJ; Behuhuma O; Vaz P; Maiga AI; Oletto A; Naniche D; Rossi P; Rojo P; Tagarro A;
BMC Public Health; 2022 Jul; 22(1):1312. PubMed ID: 35804333
[TBL] [Abstract][Full Text] [Related]
36. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
[TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy.
Nachega JB; Chaisson RE; Goliath R; Efron A; Chaudhary MA; Ram M; Morroni C; Schoeman H; Knowlton AR; Maartens G
AIDS; 2010 Jun; 24(9):1273-80. PubMed ID: 20453627
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with non-attendance at scheduled infant follow-up visits in an observational cohort of HIV-exposed infants in South Africa, 2012-2014.
Ngandu NK; Jackson D; Lombard C; Nsibande DF; Dinh TH; Magasana V; Mogashoa M; Goga AE
BMC Infect Dis; 2019 Sep; 19(Suppl 1):788. PubMed ID: 31526372
[TBL] [Abstract][Full Text] [Related]
39. Community-facility linkage models and maternal and infant health outcomes in Malawi's PMTCT/ART program: A cohort study.
Herce ME; Chagomerana MB; Zalla LC; Carbone NB; Chi BH; Eliya MT; Phiri S; Topp SM; Kim MH; Wroe EB; Chilangwa C; Chinkonde J; Mofolo IA; Hosseinipour MC; Edwards JK
PLoS Med; 2021 Sep; 18(9):e1003780. PubMed ID: 34534213
[TBL] [Abstract][Full Text] [Related]
40. Mother-child separation among women living with HIV and their children in the first four years postpartum in South Africa.
Mogoba P; Phillips TK; le Roux S; Mukonda EE; Brittain K; Gomba Y; Zerbe A; Abrams EJ; Myer L
Trop Med Int Health; 2021 Feb; 26(2):173-183. PubMed ID: 33159710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
